UVA School of Medicine emeritus professor Dr. Frederick G. Hayden helped design the trial and presented the results Wednesday ...

An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on ...

An international clinical trial has identified a medication that can help prevent symptomatic COVID-19 in people exposed within households.

Bacteriophages, the most abundant life form on Earth, infect bacterial cells and influence the structure of the microbial ...

In a recent op-ed, HHS secretary RFK Jr. shared his “deep concern” about the measles outbreak and its rapid escalation.

A new study suggests Paxlovid may not reduce the risk of covid-19 hospitalizations and all-cause deaths in vaccinated adults ...

Prenatal exposure to per- and polyfluoroalkyl substances (PFAS), so-called forever chemicals, in drinking water had ...

Between the 2017-2018 and 2023-2024 influenza seasons, the use of antiviral therapy in pediatric patients with influenza declined in both inpatient and outpatient settings.

In her lab, Mary McCourt is busy developing a next-generation anti-viral therapy while training – and working alongside – the ...

Red flags for drug resistance in human patients include the development of influenza after receiving antiviral prophylaxis with a NA inhibitor, lack of clinical improvement despite treatment with ...